Abiopharma

🔍 Carter Charles J. (Executive)

Company: PACKAGING CORP OF AMERICA (PKG)

Report Date: 2026-03-27

Detailed Transactions and Holdings:

• Acquired 8,282 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: false | shares_owned_after: 53,496.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 634 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: false | shares_owned_after: 54,130.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 3,509 shares of Common Stock at $212.25 per share (Direct)
  Date: 2026-03-27 | Code: F | equity_swap_involved: false | shares_owned_after: 50,621.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: H | nature_of_ownership: Through 401(k) plan | shares_owned_after: 6,550.00

Footnotes:

• F1: On March 27, 2026, the compensation subcommittee of the compensation committee of the registrant's board of directors certified attainment of the performance measure under the TSR performance units awarded to the reporting person on February 22, 2023. Performance was achieved at 200%. The units paid out on the date of certification.
• F2: Payout in shares of accumulated dividends on vesting performance units.
• F3: Pursuant to the terms of the Company's Long-Term Equity Incentive Plan, the Company withheld shares to cover the withholding tax obligation associated with equity awards vesting on the transaction date.